Stay updated on Pembrolizumab for Biliary Tract Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab for Biliary Tract Cancer Clinical Trial page.

Latest updates to the Pembrolizumab for Biliary Tract Cancer Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedRevision history updated: added v3.5.0 and removed v3.4.3.SummaryDifference0.1%

- Check27 days agoChange DetectedRevision label updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check55 days agoChange DetectedAdded Revision: v3.4.2. Removed the funding-status notice and the previous Revision: v3.4.1.SummaryDifference0.4%

- Check62 days agoChange DetectedAdded a government funding lapse notice banner. Updated the site revision from v3.4.0 to v3.4.1.SummaryDifference0.4%

- Check69 days agoChange DetectedThe changes add a glossary display toggle and update page metadata by introducing 'Last Update Submitted that Met QC Criteria', 'No FEAR Act Data', and 'Revision: v3.4.0', while removing the older labels 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4'. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check83 days agoChange DetectedRevision label updated from v3.3.3 to v3.3.4; no visible content or layout changes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab for Biliary Tract Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab for Biliary Tract Cancer Clinical Trial page.